Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: A prospective observational study of 553 cases

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Cordel, Hugues ^a,b   Cailhol, Johann ^a,b   Matheron, Sophie ^c   Bloch, Martine ^d   Godineau, Nadine ^e   Consigny, Paul Henri ^f   Gros, Hélène ^g   Campa, Pauline ^h   Bourée, Patrice ⁱ   Fain, Olivier ^j   Ralaimazava, Pascal ^a   Bouchaud, Olivier ^a,b  

^a AVICENNE HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c BICHAT HOSPITAL   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e DELAFONTAINE HOSPITAL   (France)

^f INSTITUT PASTEUR   (France)

^g Centre Hospitalier Robert Ballanger CHRB   (France)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

ⁱ BICÊTRE HOSPITAL   (France)

^j HÔPITAL JEAN VERDIER   (France)

more..

Author keywords

Atovaquone proguanil; Imported; Malaria; Tolerance; Uncomplicated

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; DOXYCYCLINE; MEFLOQUINE; PROGUANIL; QUININE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AFRICA; AGED; ANXIETY; ARTHRALGIA; ARTICLE; ASIA; CARIBBEAN ISLANDS; CHEMOPROPHYLAXIS; CHILD; COHORT ANALYSIS; CYTOLYSIS; DIARRHEA; DRUG TOLERANCE; DRUG TREATMENT FAILURE; FEVER; FOLLOW UP; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MYALGIA; NAUSEA AND VOMITING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARASITE CLEARANCE; PROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SKIN DISEASE; TRAVEL;

ADOLESCENT; ADULT; AFRICA; AGED; ANTIMALARIALS; ASIA; ATOVAQUONE; CHILD; DRUG COMBINATIONS; FEMALE; FRANCE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PROGUANIL; TRANSIENTS AND MIGRANTS; TRAVEL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887366412     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-399     Document Type: Article

References (44)

1. WHO, World malaria report 2010 Geneva: World Health Organization 2010
2. World Health Organization Regional Office for Europe, Centralized information system for infectious diseases (CISID)
3. French Institute of Public Health, InVS, French national reference centre for malaria-Report 2011 Saint-Maurice, France: French Institute of Public Health, InVS 2012 79
4. Therapy of uncomplicated falciparum malaria in Europe: MALTHER-a prospective observational multicentre study. Bouchaud O, Muehlberger N, Parola P, Calleri G, Matteelli A, Peyerl-Hoffmann G, Mechaï F, Gautret P, Clerinx J, Kremsner PG, Jelinek T, Kaiser A, Beltrame A, Schmid M, Kern P, Probst M, Bartoloni A, Weinke T, Grobusch MP, Malar J 2012 11 212 10.1186/1475-2875-11-212 22720832
5. Management and prevention of imported Plasmodium falciparum malaria (Revision 2007 of the 1999 Consensus Conference) (in French). Société de Pathologie Infectieuse de Langue Française, Med Mal Infect 2008 38 68 117 18646361
6. Lapinone, menoctone, hydroxynaphtoquinones and similar structures. Hudson AT, Handbook of experimental pharmacology, antimalarial drugs Berlin-Heidelberg: Springer Verlag, Peters WRW, 1984 343 361
7. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. Hudson AT, Randall AW, Fry M, Ginger CD, Hill B, Latter VS, McHardy N, Williams RB, Parasitology 1985 90 45 55 10.1017/ S0031182000049003 3920634 (Pubitemid 15151736)
8. Chemotherapy. Gutteridge WE, Modern parasitology Oxford: Blackwell Scientific Publications, FG C, 1993 218 239
9. Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. Chiodini PL, Conlon CP, Hutchinson DB, Farquhar JA, Hall AP, Peto TE, Birley H, Warrell DA, J Antimicrob Chemother 1995 36 1073 1078 10.1093/jac/36.6.1073 8821609 (Pubitemid 26036559)
10. Atovaquone-proguanil compared with chloroquine and chloroquine- sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. Bustos DG, Canfield CJ, Canete-Miguel E, Hutchinson DB, J Infect Dis 1999 179 1587 1590 10.1086/314770 10228090 (Pubitemid 29246618)
11. Atovaquone and proguanil for the treatment of malaria in Brazil. De Alencar FE, Cerutti C, Durlacher RR, Boulos M, Alves FP, Milhous W, Pang LW, J Infect Dis 1997 175 1544 1547 10.1086/516497 9180204 (Pubitemid 27225068)
12. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Looareesuwan S, Wilairatana P, Chalermarut K, Rattanapong Y, Canfield CJ, Hutchinson DB, Am J Trop Med Hyg 1999 60 526 532 10348224 (Pubitemid 29233106)
13. Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in Zambia. Mulenga M, Sukwa TY, Canfield CJ, Hutchinson DB, Clin Ther 1999 21 841 852 10.1016/S0149-2918(99)80006-X 10397379 (Pubitemid 29291442)
14. Atovaquone and proguanil for Plasmodium falciparum malaria. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG, Lancet 1996 347 1511 1514 10.1016/S0140-6736(96)90671-6 8684102 (Pubitemid 26162641)
15. Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Bouchaud O, Monlun E, Muanza K, Fontanet A, Scott T, Goetschel A, Chulay JD, Le Bras J, Danis M, Le Bras M, Coulaud JP, Gentilini M, Am J Trop Med Hyg 2000 63 274 279 11421377 (Pubitemid 32537563)
16. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan. J. Hitani A, Nakamura T, Ohtomo H, Nawa Y, Kimura M, Infect Chemother 2006 12 277 282 10.1007/s10156-006-0465-8 (Pubitemid 44760508)
17. The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. Van Agtmael M, Bouchaud O, Malvy D, Delmont J, Danis M, Barette S, Gras C, Bernard J, Touze JE, Gathmann I, Mull R, Int J Antimicrob Agents 1999 12 159 169 10.1016/S0924-8579(99)00070-9 10418762 (Pubitemid 29276920)
18. [Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria-report of 112 cases] (in French). Malvy D, Djossou F, Vatan R, Pistone T, Etienne G, Longy-Boursier M, Le Bras M, Med Trop (Mars) 2002 62 229 231 12244916 (Pubitemid 37168804)
19. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark. Thybo S, Gjorup I, Ronn AM, Meyrowitsch D, Bygberg IC, J Travel Med 2004 11 220 223 15541224
20. [Retrospective analysis of 107 imported adult cases of malaria: experience report of uncomplicated falciparum malaria treatment in adults with oral atovaquone-proguanil] (in French). Vatan R, Pistone T, Millet P, Etienne G, Mercié P, Longy-Boursier M, Malvy D, Presse Med 2006 35 571 577 10.1016/S0755-4982(06)74642-5 16614596 (Pubitemid 43907152)
21. Selective ambulatory management of imported falciparum malaria: a 5-year prospective study. Bottieau E, Clerinx J, Colebunders R, Van den Enden E, Wouters R, Demey H, Van Esbroeck M, Vervoort T, Van Gompel A, Van den Ende J, Eur J Clin Microbiol Infect Dis 2007 26 181 188 10.1007/s10096-007-0264-x 17297605
22. [Imported malaria at the Marseilles Hôpital-Nord, France: a prospective study on 352 cases between 2001 and 2003] (in French). Parola P, Minodier P, Soula G, Jaffré Y, Badiaga S, Retornaz K, Garnier JM, Delmont J, Parzy D, Brouqui P, Med Mal Infect 2005 35 482 488 10.1016/j.medmal.2005.05. 006 16271842 (Pubitemid 41779399)
23. Treatment of imported malaria in adults: a multicentre study in France. Ranque S, Marchou B, Malvy D, Adehossi E, Laganier R, Tissot-Dupont H, Lotte A, Dydymsky S, Durant J, Stahl JP, Bosseray A, Gaillat J, Sotto A, Cazorla C, Ragneau JM, Brouqui P, Delmont J, QJM 2005 98 737 743 10.1093/qjmed/hci110 16126742 (Pubitemid 41548551)
24. [Imported malaria in University Hospital Center of Bordeaux, France, 2000-2007: a comparison study with the French national epidemiological data] (in French). Pistone T, Diallo A, Receveur MC, Mansour R, Roger-Schmeltz J, Millet P, Malvy D, Bull Soc Pathol Exot 2010 103 104 110 10.1007/s13149-010-0045-4 20349344
25. New WHO guidelines for the treatment of malaria. Reyburn H, BMJ 2010 340 2637 10.1136/bmj.c2637 20511305
26. Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JP, Bisoffi Z, Matteelli A, Clerinx J, Corachán M, Puente S, Gjørup I, Harms G, Kollaritsch H, Kotlowski A, Björkmann A, Delmont JP, Knobloch J, Nielsen LN, Cuadros J, Hatz C, Beran J, Schmid ML, Schulze M, Lopez-Velez R, Fleischer K, Kapaun A, McWhinney P, Kern P, Atougia J, Fry G, Da Cunha S, Boecken G, Clin Infect Dis 2002 34 572 576 10.1086/338235 11803507 (Pubitemid 34165317)
27. Treatment of imported malaria in an ambulatory setting: prospective study. D'Acremont V, Landry P, Darioli R, Stuerchler D, Pécoud A, Genton B, BMJ 2002 324 875 877 10.1136/bmj.324.7342.875 11950734
28. Imported malaria in the 1990s: a review of 101 patients. Kockaerts Y, Vanhees S, Knockaert DC, Verhaegen J, Lontie M, Peetermans WE, Eur J Emerg Med 2001 8 287 290 10.1097/00063110-200112000-00007 11785595
29. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study. Hatz C, Soto J, Nothdurft HD, Zoller T, Weitzel T, Loutan L, Bricaire F, Gay F, Burchard G-D, Andriano K, Lefèvre G, De Palacios PI, Genton B, Am J Trop Med Hyg 2008 78 241 247 18256423 (Pubitemid 351844558)
30. Atovaquone-proguanil for treating uncomplicated malaria. Osei-Akoto A, Orton L, Owusu-Ofori SP, Cochrane Database Syst Rev 2005 19 4 D004529
31. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam. Giao PT, De Vries PJ, Hung LQ, Binh TQ, Nam NV, Kager PA, Trop Med Int Health 2004 9 209 216 10.1046/j.1365-3156.2003.01180.x 15040557 (Pubitemid 38250807)
32. The clinical efficacy of artemether/lumefantrine (Coartem). Makanga M, Krudsood S, Malar. J 2009 8 1 5 10.1186/1475-2875-8-5
33. Controlled trial of 3-day quinine-clindamycin treatment versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics. Parola P, Ranque S, Badiaga S, Niang M, Blin O, Charbit JJ, Delmont J, Brouqui P, Antimicrob. Agents Chemother 2001 45 932 935 10.1128/AAC.45.3.932-935.2001 11181383 (Pubitemid 32182048)
34. Plasmodium falciparum malaria and atovaquone-proguanil treatment failure. Durand R, Prendki V, Cailhol J, Hubert V, Ralaimazava P, Massias L, Bouchaud O, Le Bras J, Emerg Infect Dis 2008 14 320 322 10.3201/eid1402.070945 18258131 (Pubitemid 351213688)
35. Clinical characteristics of imported malaria in Japan: analysis at a referral hospital. Miura T, Kimura M, Koibuchi T, Endo T, Nakamura H, Odawara T, Wataya Y, Nakamura T, Iwamoto A, Am J Trop Med Hyg 2005 73 599 603 16172489 (Pubitemid 41324268)
36. Travel health risk perceptions and prevention behaviors of US study abroad students. Hartjes LB, Baumann LC, Henriques JB, J Travel Med 2009 16 338 343 10.1111/j.1708-8305.2009.00322.x 19796105
37. Use of drugs, perceived drug efficacy and preferred providers for febrile children: implications for home management of fever. Rutebemberwa E, Nsabagasani X, Pariyo G, Tomson G, Peterson S, Kallander K, Malar J 2009 8 131 10.1186/1475-2875-8-131 19523220
38. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Hussein Z, Eaves J, Hutchinson DB, Canfield CJ, Clin Pharmacol Ther 1997 61 518 530 10.1016/S0009-9236(97)90132-6 9164414 (Pubitemid 27261756)
39. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria: malarone clinical trials study group. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB, Am J Trop Med Hyg 1999 60 533 541 10348225 (Pubitemid 29233107)
40. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K, Scott L, Drugs 2003 63 597 623 10.2165/00003495-200363060-00006 12656656 (Pubitemid 36384624)
41. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Boggild AK, Parise ME, Lewis LS, Kain KC, Am J Trop Med Hyg 2007 76 208 223 17297027 (Pubitemid 351627765)
42. Malaria-related Anaemia. Menendez C, Fleming AF, Alonso PL, Parasitol Today 2000 16 469 476 10.1016/S0169-4758(00)01774-9 11063857
43. Factors contributing to anemia after uncomplicated falciparum malaria. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, Ter Kuile F, Chongsuphajaisiddhi T, White NJ, Am J Trop Med Hyg 2001 65 614 622 11716124 (Pubitemid 33134602)
44. Evaluation of the riamet® versus malarone® in the treatment of uncomplicated malaria-full text view-clinicaltrials.gov http://clinicaltrials. gov/ct2/show/NCT01150344